Clinical Trials Directory

Trials / Conditions / Carcinoma, Basal Cell

Carcinoma, Basal Cell

42 registered clinical trials studyying Carcinoma, Basal Cell2 currently recruiting.

StatusTrialSponsorPhase
RecruitingNicotinamide Chemoprevention for Keratinocyte Carcinoma in Solid Organ Transplant Recipients - Pivotal Trial
NCT05955924
Women's College HospitalPhase 3
Active Not RecruitingHIFU for Treatment of Non-nodular and Recurrent BCC
NCT05133427
Joergen SerupN/A
RecruitingOral Hedgehog Inhibitors in the Treatment of Basal Cell Carcinoma in the Netherlands: a Prospective Registrati
NCT05463757
Maastricht University Medical Center
CompletedLaser Treatment of Basal Cell Carcinoma Under Imaging Guidance
NCT05138328
Henry Ford Health SystemN/A
UnknownIntratumoral Administration of Daromun in Non-melanoma Skin Cancer Patients
NCT04362722
Philogen S.p.A.Phase 2
CompletedTreatment Duration Increment and Pharmacodynamic Study of CX-4945 in Patients With Basal Cell Carcinoma (BCC)
NCT03897036
Senhwa Biosciences, Inc.Phase 1
UnknownSkin Cancer Prevention With Nicotinamide in Transplant Recipients - Pilot Trial
NCT03769285
Women's College HospitalPhase 2
TerminatedEfficiency of Presurgical Basal Cell Carcinoma Margin Mapping
NCT03420846
Michelson Diagnostics Ltd.N/A
UnknownIntraoperative Detection of Residual BCC by Fast Raman
NCT03482622
University of Nottingham
CompletedTopical Laser-assisted Combination Chemotherapy for Basal Cell Carcinoma- a Clinical Study
NCT03541252
Merete HaedersdalPhase 1 / Phase 2
CompletedBasal Cell Carcinomas Treated With Ablative Fractional Laser and Ingenol Mebutate
NCT03569345
Merete HaedersdalPhase 1 / Phase 2
TerminatedEPR Tumor Oximetry With CE India Ink
NCT03321903
Philip Schaner
CompletedPD-1 in Patients With Advanced Basal Cell Carcinoma Who Experienced Progression of Disease on Hedgehog Pathway
NCT03132636
Regeneron PharmaceuticalsPhase 2
TerminatedTo Assess The Efficacy And Safety Of Vismodegib And Radiotherapy In Advanced Basal Cell Carcinoma
NCT02956889
Istituto Clinico HumanitasPhase 2
UnknownOptical Imaging for Preoperative Delineation of Nonmelanoma Skin Cancers
NCT02666833
Massachusetts General Hospital
CompletedEarly Detection of Skin Cancer With Sensor Technology
NCT02668614
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sN/A
CompletedReflectance Confocal Microscopy in Basal Cell Carcinoma
NCT02623101
Radboud University Medical CenterN/A
CompletedObservational Study to Determine the Effectiveness and Safety of Vismodegib (Erivedge®) in Participants With L
NCT02674009
Hoffmann-La Roche
CompletedVISmodegib for ORbital and Periocular Basal Cell Carcinoma
NCT02436408
University of Michigan Rogel Cancer CenterPhase 4
UnknownSuperficial Basal Cell Cancer's Photodynamic Therapy: Comparing Three Photosensitizers: HAL and BF-200 ALA Ver
NCT02367547
Joint Authority for Päijät-Häme Social and Health CarePhase 1 / Phase 2
TerminatedPilot Study of Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma
NCT02303041
Anne ChangPhase 2
CompletedOne-stop-shop Study for Treatment of Basal Cell Carcinoma Using Reflectance Confocal Microscopy
NCT02285790
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)N/A
CompletedTopical Green Tea Ointment in Treatment of Superficial Skin Cancer
NCT02029352
Maastricht University Medical CenterPhase 2 / Phase 3
CompletedSpanish Registry of Mohs Surgery
NCT02310503
Fundación Academia Española de Dermatología
CompletedStudy of Electronic Brachytherapy for Cutaneous Basal Cell Carcinoma
NCT02939027
Instituto de Investigacion Sanitaria La FeN/A
CompletedNew Versus Approved Methyl-aminolevulinate Photodynamic Therapy (MAL-PDT) Regime in Basal Cell Carcinoma (BCC)
NCT01482104
Norwegian University of Science and TechnologyN/A
CompletedPost-occlusive Reactive Hyperemia and Basal-cell Carcinoma
NCT01455363
Institut CurieN/A
CompletedA Study of TAK-441 in Adult Patients With Advanced Nonhematologic Malignancies
NCT01204073
Millennium Pharmaceuticals, Inc.Phase 1
CompletedCSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial
NCT00847912
VA Office of Research and DevelopmentPhase 4
UnknownImiquimod 5% Cream for the Treatment of Periocular Basal Cell Carcinoma
NCT00803907
University of Sao PauloPhase 4
UnknownMohs Versus Traditional Surgery - Basal-Cell Carcinomas (BCC)
NCT00699829
Hospital Ambroise Paré Paris
SuspendedCurettage Versus Excision in Nodular and Superficial Basal Cell Carcinomas
NCT00515970
University Hospital TuebingenN/A
UnknownRecurrence Rate and Esthetic Outcome After Excision of Basal Cell Carcinomas Excluded From Trial NCT00515970
NCT00639652
University Hospital Tuebingen
CompletedAnalysis of Melanocytes (Pigment Cells) in Sun-Exposed Skin
NCT00875381
Mayo Clinic
CompletedA Randomised Study Comparing Tissue Conservation in Conventional Versus Mohs' Surgery of Basal Cell Carcinoma
NCT00571363
NHS TaysideN/A
CompletedAldara for the Treatment of Large and/or Multiple sBCC
NCT00189280
MEDA Pharma GmbH & Co. KGPhase 3
CompletedDebulking Effect of Curretage on Basal Cell Carcinomas - a Histological Assessment.
NCT00237107
Norwegian University of Science and TechnologyN/A
CompletedSafety and Efficacy Study of Imiquimod 5% Cream Applied 3x Per Week for 8 or 12 Weeks in Low Risk Nodular Basa
NCT00204555
University Hospital TuebingenPhase 4
CompletedCytodiagnosis of Basal Cell Carcinoma and Actinic Keratosis Using Papanicolaou and May-grunwald-giemsa Stained
NCT00218868
Norwegian University of Science and Technology
CompletedUltrasound Biomicroscopy - Apoptosis
NCT00188370
University Health Network, TorontoPhase 2
CompletedDetermine the Efficacy of Topical Tretinoin Cream for the Prevention of Nonmelanoma Skin Cancer
NCT00007631
US Department of Veterans AffairsPhase 3
CompletedDMSO-PDT of BCC - A 6 Year Follow up
NCT00218829
Norwegian University of Science and Technology